Voltar
Artigo Acesso aberto Revisado por pares
BIBTEX RIS

Anti‐cathepsin D immunotherapy triggers both innate and adaptive anti‐tumour immunity in breast cancer

2023; Wiley; Linguagem: Inglês

10.1111/bph.16291

ISSN

1476-5381

Autores

Timothée David, Aude Mallavialle, Julien Faget, Lindsay B. Alcaraz, Marion Lapierre, Pénélope Desroys du Roure, Valérie Laurent‐Matha, Hanane Mansouri, Marta Jarlier, Pierre Martineau, Pascal Roger, Séverine Guiu, Thierry Chardès, Emmanuelle Liaudet‐Coopman,

Tópico(s)

Immune Response and Inflammation

Resumo

Triple-negative breast cancer (TNBC) has poorer outcomes than other breast cancers (BC), including HER2

Referência(s)